organophosphonates has been researched along with Mixed Tumor, Mesodermal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asbury, R; Ball, H; Blessing, JA; Podczaski, E | 1 |
1 trial(s) available for organophosphonates and Mixed Tumor, Mesodermal
| Article | Year |
|---|---|
A phase II trial of amonafide in patients with mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Imides; Isoquinolines; Leukopenia; Middle Aged; Mixed Tumor, Mesodermal; Naphthalimides; Organophosphonates; Thrombocytopenia; Uterine Neoplasms | 1998 |